CDC has issued a Health Alert Network advisory about the risk of severe arboviral neuroinvasive disease among patients who are receiving B cell-depleting or B cell-modulating medications, particularly anti-CD20 monoclonal antibodies (mAbs). Learn more at: www.cdc.gov/han/php/noti...
cdc.gov
Risk of Severe Arboviral Disease in Patients Receiving B Cell-Depleting or Modulating Medications
Risk of Severe Arboviral Disease in Patients Receiving B Cell-Depleting or Modulating Medications